talactoferrin alfa has been researched along with Kidney Neoplasms in 2 studies
talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006
Kidney Neoplasms: Tumors or cancers of the KIDNEY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-six patients with metastatic cancer who had progressed on, or were ineligible for, standard chemotherapy received single-agent oral talactoferrin." | 2.75 | Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors. ( Falchook, GS; Hayes, TG; Varadhachary, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayes, TG | 2 |
| Falchook, GS | 1 |
| Varadhachary, A | 2 |
| Jonasch, E | 1 |
| Stadler, WM | 1 |
| Bukowski, RM | 1 |
| Malik, R | 1 |
| Figlin, RA | 1 |
| Srinivas, S | 1 |
2 trials available for talactoferrin alfa and Kidney Neoplasms
| Article | Year |
|---|---|
Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal | 2010 |
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Disease-Free Survival; Drug Administration Schedule; F | 2008 |